Rapid, simple and cost-effective carbapenemase detection

Mast Group has launched the MAST CARBA PAcE for rapid carbapenemase detection in Pseudomonas, Acinetobacter and Enterobacterales.

An increase in antimicrobial resistance is one of the most urgent global challenges facing the field of healthcare.  Carbapenem-resistant bacteria are an emerging cause of healthcare-associated infection and are particularly concerning due to the high level of antimicrobial resistance coupled with the ability for widespread transmission. 

Accordingly, it is important to detect carriers quickly to prevent and control spread and also to aid antimicrobial stewardship. Mast Group has developed a colourimetric test that rapidly detects carbapenemase-producing Pseudomonas spp., Acinetobacter spp. and Enterobacterales using a chromogenic cephalosporin analogue.

MAST CARBA PAcE is a simple, cost-effective solution providing fast results within 10 minutes, conveniently containing 48 tests per kit, making it ideal for screening purposes, and supporting effective infection prevention and control.  With no special equipment required, the test can be easily adaptable to any microbiology laboratory.


Other news

Upcoming Events


Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Jun 2019

Recent advances in cancer diagnostics

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.